160 related articles for article (PubMed ID: 30921671)
1. Environmental inhibitors of the expression of cytochrome P450 17A1 in mammals.
Peng Z; Xueb G; Chen W; Xia S
Environ Toxicol Pharmacol; 2019 Jul; 69():16-25. PubMed ID: 30921671
[TBL] [Abstract][Full Text] [Related]
2. Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1.
Gonzalez E; Guengerich FP
J Biol Chem; 2017 Aug; 292(32):13168-13185. PubMed ID: 28684414
[TBL] [Abstract][Full Text] [Related]
3. CYP17A1: a biochemistry, chemistry, and clinical review.
Porubek D
Curr Top Med Chem; 2013; 13(12):1364-84. PubMed ID: 23688130
[TBL] [Abstract][Full Text] [Related]
4. Structural and kinetic basis of steroid 17α,20-lyase activity in teleost fish cytochrome P450 17A1 and its absence in cytochrome P450 17A2.
Pallan PS; Nagy LD; Lei L; Gonzalez E; Kramlinger VM; Azumaya CM; Wawrzak Z; Waterman MR; Guengerich FP; Egli M
J Biol Chem; 2015 Feb; 290(6):3248-68. PubMed ID: 25533464
[TBL] [Abstract][Full Text] [Related]
5. Stepwise binding of inhibitors to human cytochrome P450 17A1 and rapid kinetics of inhibition of androgen biosynthesis.
Guengerich FP; McCarty KD; Chapman JG; Tateishi Y
J Biol Chem; 2021 Aug; 297(2):100969. PubMed ID: 34273352
[TBL] [Abstract][Full Text] [Related]
6. Hydroxylation and lyase reactions of steroids catalyzed by mouse cytochrome P450 17A1 (Cyp17a1).
Lee SG; Kim V; Lee GH; Kim C; Jeong E; Guengerich FP; Kim D
J Inorg Biochem; 2023 Mar; 240():112085. PubMed ID: 36640554
[TBL] [Abstract][Full Text] [Related]
7. Active site proton delivery and the lyase activity of human CYP17A1.
Khatri Y; Gregory MC; Grinkova YV; Denisov IG; Sligar SG
Biochem Biophys Res Commun; 2014 Jan; 443(1):179-84. PubMed ID: 24299954
[TBL] [Abstract][Full Text] [Related]
8. Steroid 17α-hydroxylase/17, 20-lyase (cytochrome P450 17A1).
Guengerich FP; McCarty KD; Tateishi Y; Liu L
Methods Enzymol; 2023; 689():39-63. PubMed ID: 37802581
[TBL] [Abstract][Full Text] [Related]
9. Role of cytochrome b5 in the modulation of the enzymatic activities of cytochrome P450 17α-hydroxylase/17,20-lyase (P450 17A1).
Bhatt MR; Khatri Y; Rodgers RJ; Martin LL
J Steroid Biochem Mol Biol; 2017 Jun; 170():2-18. PubMed ID: 26976652
[TBL] [Abstract][Full Text] [Related]
10. Conformational selection dominates binding of steroids to human cytochrome P450 17A1.
Guengerich FP; Wilkey CJ; Glass SM; Reddish MJ
J Biol Chem; 2019 Jun; 294(26):10028-10041. PubMed ID: 31072872
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into the function of steroidogenic cytochrome P450 17A1.
Yadav R; Petrunak EM; Estrada DF; Scott EE
Mol Cell Endocrinol; 2017 Feb; 441():68-75. PubMed ID: 27566228
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the Clinically Relevant E305G Mutation in Human P450 CYP17A1.
Liu Y; Grinkova Y; Gregory MC; Denisov IG; Kincaid JR; Sligar SG
Biochemistry; 2021 Nov; 60(43):3262-3271. PubMed ID: 34662099
[TBL] [Abstract][Full Text] [Related]
13. 17alpha-hydroxylase/17,20-lyase (p450(17alpha)) inhibitors in the treatment of prostate cancer: a review.
Owen CP
Anticancer Agents Med Chem; 2009 Jul; 9(6):613-26. PubMed ID: 19601745
[TBL] [Abstract][Full Text] [Related]
14. Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer.
Maity SN; Titus MA; Gyftaki R; Wu G; Lu JF; Ramachandran S; Li-Ning-Tapia EM; Logothetis CJ; Araujo JC; Efstathiou E
Sci Rep; 2016 Oct; 6():35354. PubMed ID: 27748439
[TBL] [Abstract][Full Text] [Related]
15. Inherent steroid 17α,20-lyase activity in defunct cytochrome P450 17A enzymes.
Gonzalez E; Johnson KM; Pallan PS; Phan TTN; Zhang W; Lei L; Wawrzak Z; Yoshimoto FK; Egli M; Guengerich FP
J Biol Chem; 2018 Jan; 293(2):541-556. PubMed ID: 29212707
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome b5 Activates the 17,20-Lyase Activity of Human Cytochrome P450 17A1 by Increasing the Coupling of NADPH Consumption to Androgen Production.
Peng HM; Im SC; Pearl NM; Turcu AF; Rege J; Waskell L; Auchus RJ
Biochemistry; 2016 Aug; 55(31):4356-65. PubMed ID: 27426448
[TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents.
Wróbel TM; Rogova O; Andersen KL; Yadav R; Brixius-Anderko S; Scott EE; Olsen L; Jørgensen FS; Björkling F
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660148
[TBL] [Abstract][Full Text] [Related]
18. Structures of human steroidogenic cytochrome P450 17A1 with substrates.
Petrunak EM; DeVore NM; Porubsky PR; Scott EE
J Biol Chem; 2014 Nov; 289(47):32952-64. PubMed ID: 25301938
[TBL] [Abstract][Full Text] [Related]
19. Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR.
Estrada DF; Laurence JS; Scott EE
J Biol Chem; 2013 Jun; 288(23):17008-17018. PubMed ID: 23620596
[TBL] [Abstract][Full Text] [Related]
20. Human cytochrome P450 17A1 conformational selection: modulation by ligand and cytochrome b5.
Estrada DF; Skinner AL; Laurence JS; Scott EE
J Biol Chem; 2014 May; 289(20):14310-20. PubMed ID: 24671419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
